218 例女性乳腺癌患者行新辅助化疗及伴随分子标志物改变的临床价值
初竹秀， 赵文静， 李小燕， 孔晓丽… - 山东大学学报 …, 2021 - yxbwk.njournal.sdu.edu.cn
… can change the expressions of ER, PR and Ki-67 in breast cancer, and the expression of Ki-67
… Preoperative chemotherapy in primary operable breast cancer: results from the European …
… Preoperative chemotherapy in primary operable breast cancer: results from the European …
乳腺癌原发灶和转移灶中雌激素受体孕激素受体人表皮生长因子受体2 和Ki-67 的表达变化
袁渊， 胡赛男， 高津， 俞乔， 胡亦钦… - Chinese Journal of …, 2019 - search.ebscohost.com
… Expression discordances and clinical values of ER, PR, HER⁃2 and Ki⁃67 in primary and
metastatic breast cancer … Quantitativeanalysisof changes in ER,PRand HER2 expression in …
metastatic breast cancer … Quantitativeanalysisof changes in ER,PRand HER2 expression in …
[PDF][PDF] ER, PR, CA-153, Ki-67 的表达与乳腺癌临床病理特征及预后的相关性研究
黄增光， 荣震， 石玮， 李春姗， 陈莲 - 现代生物医学进展, 2018 - biomed.cnjournals.com
… the positive rate of Ki-67 in breast cancer tissues of different age … that the expression of ER,
PR, CA-153 and Ki-67 were … women diagnosed with breast tumours and changes introduced …
PR, CA-153 and Ki-67 were … women diagnosed with breast tumours and changes introduced …
c-FLIP (L) 在乳腺癌中表达的意义及对凋亡的调节
臧凤琳， 魏熙胤， 孙蕾娜， 孙保存 - 中国肿瘤临床, 2010 - cjco.cn
… 胞浆中,ER,PR,Ki-67定位于肿瘤细胞胞核,Her-2定位于肿瘤细胞胞… was mainly located in the
cytoplasm of breast cancer cells. … highly-expressed, the proliferation index changed into low or …
cytoplasm of breast cancer cells. … highly-expressed, the proliferation index changed into low or …
乳腺癌患者血浆D-二聚体水平与预后关系的探讨
李玲， 王丽丽， 王胜江， 于超， 刘延鹏… - 山东大学学报(医学 …, 2014 - yxbwk.njournal.sdu.edu.cn
… the changes of plasma D-dimer level in breast cancer patients… Methods A total of 92 cases
of primary breast cancer and 85 … immunoassay, and ER, PR, HER2, Ki-67 and P53 levels were …
of primary breast cancer and 85 … immunoassay, and ER, PR, HER2, Ki-67 and P53 levels were …
[PDF][PDF] 乳腺癌患者癌组织与血清HER-2 的表达及临床价值
刘小岑， 秦明明， 刘夏， 浦春 - 皖南医学院学报(J of Wannan …, 2018 - xuebao.wnmc.edu.cn
… level than those with negative expression of HER-2 and Ki-67( P… HER-2,ER,PR status
concordance in primary breast cancer … HER2/neu changes in patients with HER-2-positive primary …
concordance in primary breast cancer … HER2/neu changes in patients with HER-2-positive primary …
血清HER2-ECD 水平在乳腺癌新辅助化疗中的应用价值分析
孙佳俊， 卢仁泉， 郑慧 - 中国癌症杂志, 2019 - china-oncology.com
… samples from patients with breast cancer were collected, and … receptor, Ki-67 and HER2
status with serum HER2-ECD. Forty… HER-2/neu changes in patients with HER-2-positive primary …
status with serum HER2-ECD. Forty… HER-2/neu changes in patients with HER-2-positive primary …
[HTML][HTML] 围绝经期ER/PR+HER2-浸润性乳腺癌的临床病理特征及预后分析
谢轶群， 李曦洲， 李莉， 李恒宇 - 第二军医大学学报, 2021 - html.rhhz.net
… that lymph node metastasis, Ki-67 positive cells ≥ 60% and low PR expression were …
difference in the prognosis of ER/PR + HER2 - invasive breast cancer patients with different …
difference in the prognosis of ER/PR + HER2 - invasive breast cancer patients with different …
[PDF][PDF] Luminal B 型乳腺癌不同亚型的临床病理特征及预后生存分析
孙运坡， 金秉巍， 应学翔， 金艳凤… - Progress in Modern …, 2022 - biomed.cnjournals.com
… of 359 cases of primary Luminal B type breast cancer patients who were admitted … metastasis,
Ki-67 and PR expression in different molecular subtypes of Luminal B type breast cancer …
Ki-67 and PR expression in different molecular subtypes of Luminal B type breast cancer …
浸润性三阴性乳腺癌超声特征的临床, 病理学及免疫组织化学基础
李佳伟， 时兆婷， 侯英敏 - 中国癌症杂志, 2019 - china-oncology.com
… The primary objective of the present study was to evaluate the … ER,PR,HER2及 Ki-67表达的
检测实验步骤严格按说明书进行. … -2 expression in proliferative ki-67-positive breast cancers is …
检测实验步骤严格按说明书进行. … -2 expression in proliferative ki-67-positive breast cancers is …